Image-guided biopsy makes the use of imaging technologies in order to analyze the inside of the body. They utilized MIR, CT, ultrasound and x-ray for this procedure. The biopsy assists the medical professional to get the sample of the suspicious cell easily through the insertion of the needle into the best position. It is considered one of the best ways to collect samples as it causes no unnecessary injuries.
Market Analysis and Insights: Global Image-guided Biopsy Market
The global Image-guided Biopsy market is projected to grow from US$ 1013 million in 2024 to US$ 1652.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Image-guided Biopsy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Image-guided Biopsy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Image-guided Biopsy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Image-guided Biopsy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Image-guided Biopsy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Image-guided Biopsy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Koninklijke Philips
Siemens Healthcare
Analogic Corporation
General Electric
Varian Medical Systems
Brainlab
Medtronic
Olympus Corporation
KARL STORZ Endoscopy India
Stryker
Segment by Type
X- Ray
Ultrasound
Mammograpy
CT
MRI
Others
Segment by Application
Hospitals
Ambulatory Surgery Centers
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Image-guided Biopsy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Image-guided Biopsy companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Image-guided Biopsy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Image-guided Biopsy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 X- Ray
1.2.3 Ultrasound
1.2.4 Mammograpy
1.2.5 CT
1.2.6 MRI
1.2.7 Others
1.3 Market by Application
1.3.1 Global Image-guided Biopsy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centers
1.3.4 Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Image-guided Biopsy Market Perspective (2019-2030)
2.2 Global Image-guided Biopsy Growth Trends by Region
2.2.1 Image-guided Biopsy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Image-guided Biopsy Historic Market Size by Region (2019-2024)
2.2.3 Image-guided Biopsy Forecasted Market Size by Region (2025-2030)
2.3 Image-guided Biopsy Market Dynamics
2.3.1 Image-guided Biopsy Industry Trends
2.3.2 Image-guided Biopsy Market Drivers
2.3.3 Image-guided Biopsy Market Challenges
2.3.4 Image-guided Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Image-guided Biopsy by Players
3.1.1 Global Image-guided Biopsy Revenue by Players (2019-2024)
3.1.2 Global Image-guided Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Image-guided Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Image-guided Biopsy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Image-guided Biopsy Market Concentration Ratio
3.4.1 Global Image-guided Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Image-guided Biopsy Revenue in 2023
3.5 Global Key Players of Image-guided Biopsy Head office and Area Served
3.6 Global Key Players of Image-guided Biopsy, Product and Application
3.7 Global Key Players of Image-guided Biopsy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Image-guided Biopsy Breakdown Data by Type
4.1 Global Image-guided Biopsy Historic Market Size by Type (2019-2024)
4.2 Global Image-guided Biopsy Forecasted Market Size by Type (2025-2030)
5 Image-guided Biopsy Breakdown Data by Application
5.1 Global Image-guided Biopsy Historic Market Size by Application (2019-2024)
5.2 Global Image-guided Biopsy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Image-guided Biopsy Market Size (2019-2030)
6.2 North America Image-guided Biopsy Market Size by Type
6.2.1 North America Image-guided Biopsy Market Size by Type (2019-2024)
6.2.2 North America Image-guided Biopsy Market Size by Type (2025-2030)
6.2.3 North America Image-guided Biopsy Market Share by Type (2019-2030)
6.3 North America Image-guided Biopsy Market Size by Application
6.3.1 North America Image-guided Biopsy Market Size by Application (2019-2024)
6.3.2 North America Image-guided Biopsy Market Size by Application (2025-2030)
6.3.3 North America Image-guided Biopsy Market Share by Application (2019-2030)
6.4 North America Image-guided Biopsy Market Size by Country
6.4.1 North America Image-guided Biopsy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Image-guided Biopsy Market Size by Country (2019-2024)
6.4.3 North America Image-guided Biopsy Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Image-guided Biopsy Market Size (2019-2030)
7.2 Europe Image-guided Biopsy Market Size by Type
7.2.1 Europe Image-guided Biopsy Market Size by Type (2019-2024)
7.2.2 Europe Image-guided Biopsy Market Size by Type (2025-2030)
7.2.3 Europe Image-guided Biopsy Market Share by Type (2019-2030)
7.3 Europe Image-guided Biopsy Market Size by Application
7.3.1 Europe Image-guided Biopsy Market Size by Application (2019-2024)
7.3.2 Europe Image-guided Biopsy Market Size by Application (2025-2030)
7.3.3 Europe Image-guided Biopsy Market Share by Application (2019-2030)
7.4 Europe Image-guided Biopsy Market Size by Country
7.4.1 Europe Image-guided Biopsy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Image-guided Biopsy Market Size by Country (2019-2024)
7.4.3 Europe Image-guided Biopsy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Image-guided Biopsy Market Size (2019-2030)
8.2 China Image-guided Biopsy Market Size by Type
8.2.1 China Image-guided Biopsy Market Size by Type (2019-2024)
8.2.2 China Image-guided Biopsy Market Size by Type (2025-2030)
8.2.3 China Image-guided Biopsy Market Share by Type (2019-2030)
8.3 China Image-guided Biopsy Market Size by Application
8.3.1 China Image-guided Biopsy Market Size by Application (2019-2024)
8.3.2 China Image-guided Biopsy Market Size by Application (2025-2030)
8.3.3 China Image-guided Biopsy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Image-guided Biopsy Market Size (2019-2030)
9.2 Asia Image-guided Biopsy Market Size by Type
9.2.1 Asia Image-guided Biopsy Market Size by Type (2019-2024)
9.2.2 Asia Image-guided Biopsy Market Size by Type (2025-2030)
9.2.3 Asia Image-guided Biopsy Market Share by Type (2019-2030)
9.3 Asia Image-guided Biopsy Market Size by Application
9.3.1 Asia Image-guided Biopsy Market Size by Application (2019-2024)
9.3.2 Asia Image-guided Biopsy Market Size by Application (2025-2030)
9.3.3 Asia Image-guided Biopsy Market Share by Application (2019-2030)
9.4 Asia Image-guided Biopsy Market Size by Region
9.4.1 Asia Image-guided Biopsy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Image-guided Biopsy Market Size by Region (2019-2024)
9.4.3 Asia Image-guided Biopsy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Image-guided Biopsy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Image-guided Biopsy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Image-guided Biopsy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Image-guided Biopsy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Koninklijke Philips
11.1.1 Koninklijke Philips Company Details
11.1.2 Koninklijke Philips Business Overview
11.1.3 Koninklijke Philips Image-guided Biopsy Introduction
11.1.4 Koninklijke Philips Revenue in Image-guided Biopsy Business (2019-2024)
11.1.5 Koninklijke Philips Recent Developments
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Details
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Image-guided Biopsy Introduction
11.2.4 Siemens Healthcare Revenue in Image-guided Biopsy Business (2019-2024)
11.2.5 Siemens Healthcare Recent Developments
11.3 Analogic Corporation
11.3.1 Analogic Corporation Company Details
11.3.2 Analogic Corporation Business Overview
11.3.3 Analogic Corporation Image-guided Biopsy Introduction
11.3.4 Analogic Corporation Revenue in Image-guided Biopsy Business (2019-2024)
11.3.5 Analogic Corporation Recent Developments
11.4 General Electric
11.4.1 General Electric Company Details
11.4.2 General Electric Business Overview
11.4.3 General Electric Image-guided Biopsy Introduction
11.4.4 General Electric Revenue in Image-guided Biopsy Business (2019-2024)
11.4.5 General Electric Recent Developments
11.5 Varian Medical Systems
11.5.1 Varian Medical Systems Company Details
11.5.2 Varian Medical Systems Business Overview
11.5.3 Varian Medical Systems Image-guided Biopsy Introduction
11.5.4 Varian Medical Systems Revenue in Image-guided Biopsy Business (2019-2024)
11.5.5 Varian Medical Systems Recent Developments
11.6 Brainlab
11.6.1 Brainlab Company Details
11.6.2 Brainlab Business Overview
11.6.3 Brainlab Image-guided Biopsy Introduction
11.6.4 Brainlab Revenue in Image-guided Biopsy Business (2019-2024)
11.6.5 Brainlab Recent Developments
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Image-guided Biopsy Introduction
11.7.4 Medtronic Revenue in Image-guided Biopsy Business (2019-2024)
11.7.5 Medtronic Recent Developments
11.8 Olympus Corporation
11.8.1 Olympus Corporation Company Details
11.8.2 Olympus Corporation Business Overview
11.8.3 Olympus Corporation Image-guided Biopsy Introduction
11.8.4 Olympus Corporation Revenue in Image-guided Biopsy Business (2019-2024)
11.8.5 Olympus Corporation Recent Developments
11.9 KARL STORZ Endoscopy India
11.9.1 KARL STORZ Endoscopy India Company Details
11.9.2 KARL STORZ Endoscopy India Business Overview
11.9.3 KARL STORZ Endoscopy India Image-guided Biopsy Introduction
11.9.4 KARL STORZ Endoscopy India Revenue in Image-guided Biopsy Business (2019-2024)
11.9.5 KARL STORZ Endoscopy India Recent Developments
11.10 Stryker
11.10.1 Stryker Company Details
11.10.2 Stryker Business Overview
11.10.3 Stryker Image-guided Biopsy Introduction
11.10.4 Stryker Revenue in Image-guided Biopsy Business (2019-2024)
11.10.5 Stryker Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Koninklijke Philips
Siemens Healthcare
Analogic Corporation
General Electric
Varian Medical Systems
Brainlab
Medtronic
Olympus Corporation
KARL STORZ Endoscopy India
Stryker
听
听
*If Applicable.
